The neurochemical pathology of Alzheimer's disease (AD), the most common cause of dementia, has received increasingly more attention. It is now evident that specific chemically-defined neurotransmitter systems are pathologically involved in this neurodegenerative disorder. Neurons affected include cholinergic neurons in the basal forebrain, GABA-containing neurons and two groups of neuropeptide-containing cells: somatostatin- and CRF-containing cells in the cerebral cortex. Other peptidergic neurons such as those containing cholecystokinin and vasoactive-intestinal peptide are apparently spared. In the present competitive renewal application we seek to continue to scrutinize in detail, the dynamic state of cholinergic neurons using tissue obtained in the Rapid Autopsy Procedure (20-60 min after death). By measuring markers of neuronal integrity, neuronal activity (high affinity choline uptake), the choline transporter itself, receptor number and affinity, and second messenger as well as third messenger responses (protein phosphorylation), the dynamic state of cholinergic neurotransmission will be assessed in several brain regions from histologically-confirmed AD and age- and sex-matched controls. In addition, we shall continue our work on peptidergic (SRIF and CRF) systems in Alzheimer's disease including assessment of the relationship between CSF and brain concentrations of these peptides. Moreover, SRIF receptor subtypes will be measured, as will functional responses of these receptors. We shall also determine the relationship between the presence of the abnormal ADassociated protein, Alz 68, and the alterations in ACh and peptidergic neurons. We shall also scrutinize alterations in GABA-containing neurons in AD. The majority of these studies are feasible because of the unique availability of the rapid autopsy tissue - our center is the only one in the world conducting this procedure. These studies will provide novel data that may well result in the development of a rational drug therapy in patients with AD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH040524-08
Application #
2244988
Study Section
Special Emphasis Panel (SRCM (M4))
Project Start
1991-05-01
Project End
1995-08-31
Budget Start
1993-09-01
Budget End
1995-08-31
Support Year
8
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Emory University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Nemeroff, C B (1998) Psychopharmacology of affective disorders in the 21st century. Biol Psychiatry 44:517-25
Owens, M J; Morgan, W N; Plott, S J et al. (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-22
Behan, D P; Khongsaly, O; Owens, M J et al. (1997) Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain. J Neurochem 68:2053-60
Bissette, G; Seidler, F J; Nemeroff, C B et al. (1996) High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Ann N Y Acad Sci 777:197-204
Nemeroff, C B; DeVane, C L; Pollock, B G (1996) Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 153:311-20
Krishnan, K R; Tupler, L A; Ritchie Jr, J C et al. (1996) Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry 40:69-71
Slotkin, T A; Nemeroff, C B; Bissette, G et al. (1994) Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest 94:696-702
Auchus, A P; Green, R C; Nemeroff, C B (1994) Cortical and subcortical neuropeptides in Alzheimer's disease. Neurobiol Aging 15:589-95
Molchan, S E; Hill, J L; Martinez, R A et al. (1993) CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology 18:509-19
Fossey, M D; Lydiard, R B; Ballenger, J C et al. (1993) Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders. J Neuropsychiatry Clin Neurosci 5:335-7

Showing the most recent 10 out of 43 publications